Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Potential of Virtual Reality in Alleviating Pain and Anxiety Among Thalassemia Patients During Intravenous Cannulation: A Crossover Clinical Trial

NCT07099196 is registered in ClinicalTrials.gov with Mohammed Bin Rashid University of Medicine and Health Sciences as lead sponsor.

NCT NCT07099196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Potential of Virtual Reality in Alleviating Pain and Anxiety Among Thalassemia Patients During Intravenous Cannulation: A Crossover Clinical Trial
Lead sponsor
Mohammed Bin Rashid University of Medicine and Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2024
Completion date
August 20, 2024
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, blood disorder, pain, thalassemia, thalassemia, beta